Edited by Kun Huang, Yunlong Liu, Yufei Huang, Lang Li, Lee Cooper, Jianhua Ruan and Zhongming Zhao.
Related articles have been published in a supplement to BMC Systems Biology.
Volume 17 Supplement 7
Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editors declare that they have no competing interests.
Indianapolis, IN, USA13-15 November 2015
Edited by Kun Huang, Yunlong Liu, Yufei Huang, Lang Li, Lee Cooper, Jianhua Ruan and Zhongming Zhao.
Related articles have been published in a supplement to BMC Systems Biology.
We summarize the 2015 International Conference on Intelligent Biology and Medicine (ICIBM 2015) and the editorial report of the supplement to BMC Genomics. The supplement includes 20 research articles selected...
Citation: BMC Genomics 2016 17(Suppl 7):524
Ion Torrent and Ion Proton are semiconductor-based sequencing technologies that feature rapid sequencing speed and low upfront and operating costs, thanks to the avoidance of modified nucleotides and optical m...
Citation: BMC Genomics 2016 17(Suppl 7):521
Improved DNA sequencing methods have transformed the field of genomics over the last decade. This has become possible due to the development of inexpensive short read sequencing technologies which have now res...
Citation: BMC Genomics 2016 17(Suppl 7):507
Most existing tools for detecting next-generation sequencing-based splicing events focus on generic splicing events. Consequently, special types of non-canonical splicing events of short mRNA regions (IRE1α ta...
Citation: BMC Genomics 2016 17(Suppl 7):503
The advancement of the next-generation sequencing technology enables mapping gene expression at the single-cell level, capable of tracking cell heterogeneity and determination of cell subpopulations using sing...
Citation: BMC Genomics 2016 17(Suppl 7):508
Lipopolysaccharide (LPS) is a gram-negative bacterial antigen that triggers a series of cellular responses. LPS pre-conditioning was previously shown to improve the therapeutic efficacy of bone marrow stromal ...
Citation: BMC Genomics 2016 17(Suppl 7):509
Streptomycetes are soil-dwelling Gram-positive bacteria that are best known as the major producers of antibiotics used in the pharmaceutical industry. The evolution of exceptionally powerful transporter system...
Citation: BMC Genomics 2016 17(Suppl 7):510
We recently reported the identification of Bacillus sp. NRRL B-14911 that induces heart autoimmunity by generating cardiac-reactive T cells through molecular mimicry. This marine bacterium was originally isolated...
Citation: BMC Genomics 2016 17(Suppl 7):511
The objective of this research was to investigate the variation of gene expression in the blood transcriptome profile of Chinese Holstein cows associated to the milk yield traits.
Citation: BMC Genomics 2016 17(Suppl 7):512
Somatic mutations can be used as potential biomarkers for subtyping and predicting outcomes for cancer patients. However, cancer patients often carry many somatic mutations, which do not always concentrate on ...
Citation: BMC Genomics 2016 17(Suppl 7):513
We considered the prediction of cancer classes (e.g. subtypes) using patient gene expression profiles that contain both systematic and condition-specific biases when compared with the training reference datase...
Citation: BMC Genomics 2016 17(Suppl 7):549
Tumor suppressor genes (TSGs) encode the guardian molecules to control cell growth. The genomic alteration of TSGs may cause tumorigenesis and promote cancer progression. So far, investigators have mainly stud...
Citation: BMC Genomics 2016 17(Suppl 7):532
Sensitive detection of low-frequency single nucleotide variants carries great significance in many applications. In cancer genetics research, tumor biopsies are a mixture of normal and tumor cells from various...
Citation: BMC Genomics 2016 17(Suppl 7):514
Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer. Recent large-scale next-generation sequencing analyses reveal that PBRM1 is the second most frequently mutated gene harboring many...
Citation: BMC Genomics 2016 17(Suppl 7):515
Clinical proteomics application aims at solving a specific clinical problem within the context of a clinical study. It has been growing rapidly in the field of biomarker discovery, especially in the area of ca...
Citation: BMC Genomics 2016 17(Suppl 7):522
Glioblastoma (GBM) is the most common and aggressive brain tumors. It has poor prognosis even with optimal radio- and chemo-therapies. Since GBM is highly heterogeneous, drugs that target on specific molecular...
Citation: BMC Genomics 2016 17(Suppl 7):516
In combination with gene expression profiles, the protein interaction network (PIN) constructs a dynamic network that includes multiple functional modules. Previous studies have demonstrated that rifampin can ...
Citation: BMC Genomics 2016 17(Suppl 7):517
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation and destruction of synovial joints. RA affects up to 1 % of the population worldwide. Currently, there are no drugs that ...
Citation: BMC Genomics 2016 17(Suppl 7):518
Proper cell models for breast cancer primary tumors have long been the focal point in the cancer’s research. The genomic comparison between cell lines and tumors can investigate the similarity and dissimilarit...
Citation: BMC Genomics 2016 17(Suppl 7):525
Gene co-expression network analysis (GCNA) is widely adopted in bioinformatics and biomedical research with applications such as gene function prediction, protein-protein interaction inference, disease marker...
Citation: BMC Genomics 2016 17(Suppl 7):519
The recent advent of the state-of-art high throughput sequencing technology, known as Methylated RNA Immunoprecipitation combined with RNA sequencing (MeRIP-seq) revolutionizes the area of mRNA epigenetics and...
Citation: BMC Genomics 2016 17(Suppl 7):520
Speed
79 days to first decision for reviewed manuscripts only
60 days to first decision for all manuscripts
177 days from submission to acceptance
20 days from acceptance to publication
Citation Impact
3.594 - 2-year Impact Factor
4.093 - 5-year Impact Factor
1.140 - Source Normalized Impact per Paper (SNIP)
1.629 - SCImago Journal Rank (SJR)
Usage
5,661,309 Downloads
4,146 Altmetric Mentions
The editors of BMC Genomics support initiatives that expedite the peer review process and are happy to consider manuscripts that have been reviewed in Peerage of Science. Please indicate in your cover letter if this applies to your manuscript.